According to an international research team, an antibiotic, kanglemycin A , which is related to the antibiotic rifampicin, is effective against the drug-resistant strains of Mycobacterium tuberculosis (bacteria causing tuberculosis). Molecular biology, chemistry,  X-ray crystallography, and microbiology were used to show the activity of the compound.